Diagnostic Accuracy of Plasma Biomarkers for Mild Traumatic Brain Injury in Older Adults - Takeaways - MDSpire

Diagnostic Accuracy of Plasma Biomarkers for Mild Traumatic Brain Injury in Older Adults

  • By

  • Gershon Spitz

  • Jake Mitchell

  • Beatrice Duarte Martins

  • Abigail Astridge

  • Charlotte Copas

  • William T. O’Brien

  • Georgia F. Symons

  • Meng Law

  • Terence J. O’Brien

  • Matthew P. Pase

  • Jennie L. Ponsford

  • Biswadev Mitra

  • Stuart J. McDonald

  • Sandy R. Shultz

  • May 29, 2026

  • 0 min

Share

  • 1

    Mild traumatic brain injury (mTBI) poses significant health risks for older adults, leading to higher hospitalization and mortality rates.

  • 2

    Diagnostic challenges for mTBI in older adults arise from overlapping symptoms with age-related conditions and cognitive impairments.

  • 3

    Blood-based biomarkers like GFAP, UCH-L1, and NfL show promise for improving mTBI diagnosis in older patients presenting within 72 hours.

  • 4

    This study aims to establish age- and sex-adjusted diagnostic thresholds for biomarkers and assess their utility in ambiguous mTBI cases.

  • 5

    The research was conducted at The Alfred Hospital Emergency Department, focusing on a comprehensive evaluation of head injury presentations in older adults.

Original Source(s)

Diagnostic Accuracy of Plasma Biomarkers for Mild Traumatic Brain Injury in Older Adults

  • by Gershon Spitz, Jake Mitchell, Beatrice Duarte Martins, Abigail Astridge, Charlotte Copas, William T. O’Brien, Georgia F. Symons, Meng Law, Terence J. O’Brien, Matthew P. Pase, Jennie L. Ponsford, Biswadev Mitra, Stuart J. McDonald, Sandy R. Shultz

  • May 29, 2026

Related Content

Multidisciplinary perspectives on pediatric nurse prescribing: a mixed-methods analysis of attitudes and consensus

Case Report: Alocasia poisoning presenting with marked QTc prolongation and a MINOCA-like phenotype

Error in Methods

  • May 26, 2026